232 related articles for article (PubMed ID: 25935648)
21. Recent advances in the discovery and development of factor XI/XIa inhibitors.
Al-Horani RA; Afosah DK
Med Res Rev; 2018 Sep; 38(6):1974-2023. PubMed ID: 29727017
[TBL] [Abstract][Full Text] [Related]
22. A synthetic glycosaminoglycan mimetic blocks HSV-1 infection in human iris stromal cells.
Majmudar H; Hao M; Sankaranarayanan NV; Zanotti B; Volin MV; Desai UR; Tiwari V
Antiviral Res; 2019 Jan; 161():154-162. PubMed ID: 30481525
[TBL] [Abstract][Full Text] [Related]
23. Design and synthesis of novel proline based factor XIa selective inhibitors as leads for potential new anticoagulants.
Hussain Z; Cooke AJ; Neelamkavil S; Brown L; Carswell E; Geissler WM; Guo Z; Hawes B; Kelly TM; Kiyoi Y; Lai K; Lesburg C; Pow E; Zang Y; Wood HB; Edmondson SD; Liu W
Bioorg Med Chem Lett; 2020 Aug; 30(16):127072. PubMed ID: 32340773
[TBL] [Abstract][Full Text] [Related]
24. Discovery of a Parenteral Small Molecule Coagulation Factor XIa Inhibitor Clinical Candidate (BMS-962212).
Pinto DJP; Orwat MJ; Smith LM; Quan ML; Lam PYS; Rossi KA; Apedo A; Bozarth JM; Wu Y; Zheng JJ; Xin B; Toussaint N; Stetsko P; Gudmundsson O; Maxwell B; Crain EJ; Wong PC; Lou Z; Harper TW; Chacko SA; Myers JE; Sheriff S; Zhang H; Hou X; Mathur A; Seiffert DA; Wexler RR; Luettgen JM; Ewing WR
J Med Chem; 2017 Dec; 60(23):9703-9723. PubMed ID: 29077405
[TBL] [Abstract][Full Text] [Related]
25. Structural Basis for Activity and Specificity of an Anticoagulant Anti-FXIa Monoclonal Antibody and a Reversal Agent.
Ely LK; Lolicato M; David T; Lowe K; Kim YC; Samuel D; Bessette P; Garcia JL; Mikita T; Minor DL; Coughlin SR
Structure; 2018 Feb; 26(2):187-198.e4. PubMed ID: 29336885
[TBL] [Abstract][Full Text] [Related]
26. Allosteric Inhibition as a New Mode of Action for BAY 1213790, a Neutralizing Antibody Targeting the Activated Form of Coagulation Factor XI.
Schaefer M; Buchmueller A; Dittmer F; Straßburger J; Wilmen A
J Mol Biol; 2019 Dec; 431(24):4817-4833. PubMed ID: 31655039
[TBL] [Abstract][Full Text] [Related]
27. Generation and characterization of aptamers targeting factor XIa.
Woodruff RS; Ivanov I; Verhamme IM; Sun MF; Gailani D; Sullenger BA
Thromb Res; 2017 Aug; 156():134-141. PubMed ID: 28644959
[TBL] [Abstract][Full Text] [Related]
28. Contributions of basic amino acids in the autolysis loop of factor XIa to serpin specificity.
Rezaie AR; Sun MF; Gailani D
Biochemistry; 2006 Aug; 45(31):9427-33. PubMed ID: 16878977
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and in vitro biological evaluation of aryl boronic acids as potential inhibitors of factor XIa.
Lazarova TI; Jin L; Rynkiewicz M; Gorga JC; Bibbins F; Meyers HV; Babine R; Strickler J
Bioorg Med Chem Lett; 2006 Oct; 16(19):5022-7. PubMed ID: 16876411
[TBL] [Abstract][Full Text] [Related]
30. Allosteric Inhibition of Factor XIIIa. Non-Saccharide Glycosaminoglycan Mimetics, but Not Glycosaminoglycans, Exhibit Promising Inhibition Profile.
Al-Horani RA; Karuturi R; Lee M; Afosah DK; Desai UR
PLoS One; 2016; 11(7):e0160189. PubMed ID: 27467511
[TBL] [Abstract][Full Text] [Related]
31. Identification of an anticoagulant peptide that inhibits both fXIa and fVIIa/tissue factor from the blood-feeding nematode Ancylostoma caninum.
Li D; He Q; Kang T; Yin H; Jin X; Li H; Gan W; Yang C; Hu J; Wu Y; Peng L
Biochem Biophys Res Commun; 2010 Feb; 392(2):155-9. PubMed ID: 20059979
[TBL] [Abstract][Full Text] [Related]
32. A simple, general approach of allosteric coagulation enzyme inhibition through monosulfated hydrophobic scaffolds.
Sidhu PS; Zhou Q; Desai UR
Bioorg Med Chem Lett; 2014 Dec; 24(24):5716-5720. PubMed ID: 25453807
[TBL] [Abstract][Full Text] [Related]
33. Development of Selective FXIa Inhibitors Based on Cyclic Peptides and Their Application for Safe Anticoagulation.
Carle V; Wu Y; Mukherjee R; Kong XD; Rogg C; Laurent Q; Cecere E; Villequey C; Konakalla MS; Maric T; Lamers C; Díaz-Perlas C; Butler K; Goto J; Stegmayr B; Heinis C
J Med Chem; 2021 May; 64(10):6802-6813. PubMed ID: 33974422
[TBL] [Abstract][Full Text] [Related]
34. Orally bioavailable pyridine and pyrimidine-based Factor XIa inhibitors: Discovery of the methyl N-phenyl carbamate P2 prime group.
Corte JR; Fang T; Pinto DJ; Orwat MJ; Rendina AR; Luettgen JM; Rossi KA; Wei A; Ramamurthy V; Myers JE; Sheriff S; Narayanan R; Harper TW; Zheng JJ; Li YX; Seiffert DA; Wexler RR; Quan ML
Bioorg Med Chem; 2016 May; 24(10):2257-72. PubMed ID: 27073051
[TBL] [Abstract][Full Text] [Related]
35. Sulphated penta-galloyl glucopyranoside (SPGG) is glycosaminoglycan mimetic allosteric inhibitor of cathepsin G.
Al-Horani RA; Afosah DK; Kar S; Aliter KF; Mottamal M
RPS Pharm Pharmacol Rep; 2023 Jan; 2(1):rqad001. PubMed ID: 36844783
[TBL] [Abstract][Full Text] [Related]
36. Inactivation of factor XIa in human plasma assessed by measuring factor XIa-protease inhibitor complexes: major role for C1-inhibitor.
Wuillemin WA; Minnema M; Meijers JC; Roem D; Eerenberg AJ; Nuijens JH; ten Cate H; Hack CE
Blood; 1995 Mar; 85(6):1517-26. PubMed ID: 7534133
[TBL] [Abstract][Full Text] [Related]
37. Substantial non-electrostatic forces are needed to induce allosteric disruption of thrombin's active site through exosite 2.
Mehta AY; Desai UR
Biochem Biophys Res Commun; 2014 Sep; 452(3):813-6. PubMed ID: 25201728
[TBL] [Abstract][Full Text] [Related]
38. Creating novel activated factor XI inhibitors through fragment based lead generation and structure aided drug design.
Fjellström O; Akkaya S; Beisel HG; Eriksson PO; Erixon K; Gustafsson D; Jurva U; Kang D; Karis D; Knecht W; Nerme V; Nilsson I; Olsson T; Redzic A; Roth R; Sandmark J; Tigerström A; Öster L
PLoS One; 2015; 10(1):e0113705. PubMed ID: 25629509
[TBL] [Abstract][Full Text] [Related]
39. Selection and characterization of a DNA aptamer inhibiting coagulation factor XIa.
Donkor DA; Bhakta V; Eltringham-Smith LJ; Stafford AR; Weitz JI; Sheffield WP
Sci Rep; 2017 May; 7(1):2102. PubMed ID: 28522812
[TBL] [Abstract][Full Text] [Related]
40. Targeting the S2 Subsite Enables the Structure-Based Discovery of Novel Highly Selective Factor XIa Inhibitors.
Yao N; Jia Z; Tian Y; Hou S; Yang X; Han J; Duan Y; Liao C; Kong Y; Xie Z
J Med Chem; 2022 Mar; 65(5):4318-4334. PubMed ID: 35220720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
